About Ophthalmic Diagnostic Devices
Ophthalmic diagnostic devices are used to identify ocular defects or deficiencies and to treat different eye disorders. These devices are used to treat cataracts, glaucoma, retinal disorders, and other refractive disorders. Eye-related problems can either occur due to an infection or can be congenital. Ophthalmic diagnostic devices are used to diagnose a wide range of eye conditions. The manufacturing of advanced ophthalmology products is rising due to increased funding by governments across the globe.
Technavio’s analysts forecast the global ophthalmic diagnostic devices market to grow at a CAGR of 5.40% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global ophthalmic diagnostic devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of ophthalmic diagnostic devices.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Ophthalmic Diagnostic Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global ophthalmic diagnostic devices market: Alconm, Carl Zeiss, NIDEK, and TOPCON.
Other Prominent Vendors in the market are: Abbott Medical Optics, Accutome, Ellex, HAAG-STREIT GROUP, Heidelberg Engineering, Kowa Medical, Luneau Technology, MEDMONT INTERNATIONAL, MicroMedical Devices, OPTOPOL Technology, OPTIKON, Quantel Medical, Reichert, Sonomed Escalon, SonoStar, Takagi Ophthalmic Instruments Europe, and US Ophthalmic.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing technological innovations in ophthalmology. Ophthalmology is the first branch of science that adopted laser technology for the treatment. Since then the sub-branches of ocular imaging, diagnostics, therapy, and surgery, are being benefited in terms of more accurate measurements and safety. Along with these, the modern lasers can provide single-cell-layer selectivity in therapy, nondamaging retinal therapy under optoacoustic temperature control and sub micrometer accuracy in three-dimensional image-guided surgery.”
According to the report, one driver in the market is rising incidence of eye-related disorders and ocular defects. Eye-related disorders are increasing globally mainly due to diabetes, rising age, and changing lifestyle. Diabetes leads to conditions like diabetic retinopathy, age-related factors can lead to AMD, and changing lifestyle can lead to cataract and low vision. A limited number of diabetic retinopathy treatments are conducted in low income countries due to lack of research, low healthcare spending, lack of trained eye care professionals, and inadequate tertiary eye-care services.
Further, the report states that one challenge in the market is lack of trained ophthalmologists. Multi-disciplinary facilities to meet the needs of ever-increasing population, and the availability of well-trained and skilled workers is important. Lack of sufficiently trained healthcare personnel, both in number and distribution, poses a challenge for ophthalmology, pharmacy, laboratory, radiography, and environmental health. Difficulties are also experienced in recruiting, retaining, training, developing, and utilizing the staff. The major constraints of this market are insufficient human resource, lack of funding by governments, and poor co-ordination between hospitals and ophthalmologists.
Alconm, Carl Zeiss, NIDEK, TOPCON, Abbott Medical Optics, Accutome, Ellex, HAAG-STREIT GROUP, Heidelberg Engineering, Kowa Medical, Luneau Technology, MEDMONT INTERNATIONAL, MicroMedical Devices, OPTOPOL Technology, OPTIKON, Quantel Medical, Reichert, Sonomed Escalon, SonoStar, Takagi Ophthalmic Instruments Europe, and US Ophthalmic.